Tag: nicotinamide adenine dinucleotide market

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expAnded supply chain intelligence, emerging startup coverage, And detailed product insights, The Business Research Company’s 2026 market reports provide more actionable And strategically valuable research.

Nicotinamide Adenine Dinucleotide Market Size Forecast: How Large Could The Market Become By 2030?

The nicotinamide adenine dinucleotide market size has seen substantial growth in recent years. It is projected to increase from $5.59 billion in 2025 to $6.48 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.1%. This historical expansion can be attributed to several factors including rising demAnd for anti-aging supplements, increased research into cellular metabolism, enhanced awareness of preventive healthcare, the broadening of nutraceutical distribution channels, And the growing embrace of wellness And biohacking products.

The nicotinamide adenine dinucleotide market is poised for significant expansion in the coming years, with projections indicating a rise to $11.65 billion by 2030, achieving a compound annual growth rate (CAGR) of 15.8%. This anticipated growth is influenced by several factors, including increased consumer expenditure on longevity And vitality products, the growing incorporation of NAD precursors into common supplements, the expansion of IV therapy And regenerative clinics, heightened pharmaceutical interest in NAD for chronic disease management, And the increasing adoption of online personalized supplement programs. Prominent trends for the forecast period include technological advancements in sustained-release And liposomal delivery methods, innovations in multi-ingredient formulations focused on longevity, developments in NAD-based active ingredients for dermatology And skincare, research And development efforts in therapeutic-grade NAD for neurological And metabolic disorders, And progress in biomarker-driven personalized supplementation platforms.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30680&type=smp&utm_source=Blogs&utm_medium=Paid&utm_campaign=Jul_PR

Nicotinamide Adenine Dinucleotide Market Growth Factors Supporting Long-Term Expansion

The nicotinamide adenine dinucleotide market is anticipated to grow as the occurrence of age-related And metabolic disorders increases. These disorders refer to health conditions like diabetes, obesity, cardiovascular diseases, And neurodegenerative disorders, all connected with aging, compromised metabolism, And cellular dysfunction. The prevalence of these conditions is on the rise due to an aging global population And the widespread adoption of unhealthy lifestyle patterns, including sedentary behavior, excessive calorie intake, And increasing obesity rates. Nicotinamide adenine dinucleotide aids in managing age-related And metabolic disorders through its vital role in cellular energy metabolism, mitochondrial function, And DNA repair processes, which are essential for maintaining metabolic health And slowing age-associated cellular decline. For example, in February 2025, the International Diabetes Federation, a Belgium-based non profit organization representing diabetes associations worldwide, projected that the number of people aged above 65 years with diabetes will reach 195.2 million, accounting for 19.6% in 2030, And climb to 276.2 million in 2045. This indicates a significant increase in the diabetes burden within aging societies over the next 25 years, with substantial public health And economic implications. Therefore, the growing prevalence of age-related And metabolic disorders is driving the expansion of the nicotinamide adenine dinucleotide market.

#Nicotinamide Adenine Dinucleotide Market Segment LAndscape And Growth Potential

The nicotinamide adenine dinucleotide market covered in this report is segmented –

1) By Product Type: Oral Nicotinamide Adenine Dinucleotide Supplements, Nicotinamide Adenine Dinucleotide And NADH Direct-Ingredient Capsules, Nicotinamide Adenine Dinucleotide Injection And Infusion Products, Specialized Anti-Aging And Metabolic Formulations, Nicotinamide Adenine Dinucleotide Precursors, Topical And Cosmetic Nicotinamide Adenine Dinucleotide Formulations

2) By Grade: Food Grade, Pharmaceutical Grade, Other Grades

3) By Distribution Channel: Online And E-commerce, Offline Channels

4) By Application: Dietary Supplements And Wellness, Pharmaceuticals And Therapeutics, Cosmetics And Dermatology, Clinical IV Therapy And Regenerative Medicine, Research And Biotechnology

5) By End User: Individual Consumers, Healthcare Providers, Pharmaceutical Companies

Subsegments:

1) By Oral Nicotinamide Adenine Dinucleotide Supplements: Energy Support Tablets, Healthy Aging Capsules, Metabolism Support Powder, Immune Wellness Tablet, Cognitive Support Capsules

2) By Nicotinamide Adenine Dinucleotide And NADH Direct-Ingredient Capsules: Nicotinamide Adenine Dinucleotide Plus Capsules, Nicotinamide Adenine Dinucleotide Reduced Capsules, Cellular Energy Enhancement Capsules, Mitochondrial Support Capsules, High Potency Nicotinamide Adenine Dinucleotide Capsules

3) By Nicotinamide Adenine Dinucleotide Injection And Infusion Products: Intravenous Nicotinamide Adenine Dinucleotide Solutions, Intramuscular Nicotinamide Adenine Dinucleotide Shots, High Concentration Nicotinamide Adenine Dinucleotide Infusions, Detoxification Support Infusions, Regenerative Wellness Infusion Blends

4) By Specialized Anti-Aging And Metabolic Formulations: Cellular Regeneration Formulas, Mitochondrial Activation Formulas, Longevity Support Formulas, Metabolic Enhancement Formulas, Detoxification Support Formulas

5) By Nicotinamide Adenine Dinucleotide Precursors: Nicotinamide Mononucleotide Tablets, Nicotinamide Riboside Capsules, Nicotinamide Tablets, Nicotinamide Adenine Dinucleotide Pathway Support Powders, Healthy Aging Precursor Blends

5) By Topical And Cosmetic Nicotinamide Adenine Dinucleotide Formulations: Anti-Aging Facial Serums, Skin Repair Moisturizers, Brightening Facial Creams, Barrier Strengthening Lotions, Eye Area Rejuvenation Gels

Nicotinamide Adenine Dinucleotide Market Industry Trends Shaping Future Revenue Growth

Companies operating in the nicotinamide adenine dinucleotide market are concentrating on developing advanced formulations, such as nicotinamide adenine dinucleotide (NAD+) skincare supplements, to combat aging And improve skin health. Nicotinamide adenine dinucleotide (NAD+) skincare supplements are defined as dietary or topical products crafted to elevate nicotinamide adenine dinucleotide (NAD+) levels in skin cells, thereby supporting cellular energy, repair, And anti-aging processes to enhance skin health And appearance. For instance, in November 2025, ChromaDex Corporation, a US-based NAD+ bioscience company, launched Tru Niagen Beauty, the first NAD+ skincare supplement available in the United States, which features a precise blend of clinically validated ingredients, including its patented nicotinamide riboside (Niagen). This formulation is intended to support cellular energy production, skin health, And overall wellness by increasing NAD+ availability, which naturally diminishes with age.

Nicotinamide Adenine Dinucleotide Market Competitive LAndscape: Who Are The Leading Companies?

Major companies operating in the nicotinamide adenine dinucleotide market are Thermo Fisher Scientific Inc., Life Extension Foundation Buyers Club Inc., Niagen Bioscience Inc., Tokyo Chemical Industry Co. Ltd., Otto Chemie Pvt. Ltd., HiMedia Laboratories Pvt. Ltd., Sichuan Benepure Pharmaceutical, F. Hoffmann-La Roche Ltd, Herbalmax Ltd., Nuray Chemicals Private Limited, Hefei Home Sunshine Pharmaceutical Technology Co. Ltd., Syncozymes Biotechnology Co. Ltd., OYC Americas Inc., Xi’an Yinherb Bio-Tech Co. Ltd., Shenzhen Hygieia Biotechnology Co. Ltd., Zhejiang Dazhan Biotechnology Co. Ltd., Willow Birch Pharma Inc., Hubei AOKS Bio-Tech Co. Ltd., Shanghai Neutan Pharmaceutical Co. Ltd., Evereen (Shanghai) Biotechnology Co. Ltd.

Access The Complete Nicotinamide Adenine Dinucleotide Market Report:

https://www.thebusinessresearchcompany.com/report/nicotinamide-adenine-dinucleotide-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Jul_PR

Nicotinamide Adenine Dinucleotide Market Leading Geography: Which Region Generates The Most Revenue?

North America was the largest region in the nicotinamide adenine dinucleotide market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nicotinamide adenine dinucleotide market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Nicotinamide Adenine Dinucleotide Market Change Between 2026 And 2030?

The nicotinamide adenine dinucleotide market size has seen rapid expansion in recent years. It is projected to grow from $5.59 billion in 2025 to $6.48 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 16.1%. The growth observed in the historic period can be attributed to factors such as increasing demand for anti-aging supplements, growing research on cellular metabolism, rising awareness of preventive healthcare, the expansion of nutraceutical distribution channels, and the increasing adoption of wellness and biohacking products.

The nicotinamide adenine dinucleotide market size is anticipated to experience substantial growth over the next few years, with projections indicating it will reach $11.65 billion by 2030, growing at a compound annual growth rate (CAGR) of 15.8%. This projected increase throughout the forecast period stems from factors such as heightened consumer spending on solutions for longevity and vitality, the increasing integration of NAD precursors into mainstream dietary supplements, the expanding establishment of IV therapy and regenerative clinics, a growing interest from pharmaceutical companies in NAD for managing chronic diseases, and the wider adoption of online personalized supplement programs. Significant trends expected during this period include technological progress in sustained-release and liposomal delivery systems, innovations in multi-ingredient formulations aimed at longevity, advancements in NAD-based active ingredients for dermatology and skincare, research and development focused on therapeutic-grade NAD for addressing neurological and metabolic disorders, and improvements in biomarker-based platforms for personalized supplementation.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30680&type=smp

Which Growth Drivers Are Expected To Support The Nicotinamide Adenine Dinucleotide Market Forward?

The increasing occurrence of age-related and metabolic conditions is anticipated to drive the expansion of the nicotinamide adenine dinucleotide market in the future. These disorders encompass health issues like diabetes, obesity, cardiovascular ailments, and neurodegenerative conditions, all linked to aging, compromised metabolism, and cellular malfunction. Their prevalence is increasing due to aging global populations and the widespread adoption of unhealthy lifestyles, including sedentary habits, excessive caloric consumption, and growing obesity levels. Nicotinamide adenine dinucleotide assists in addressing age-related and metabolic disorders by critically contributing to cellular energy metabolism, mitochondrial activity, and DNA repair mechanisms, which are vital for upholding metabolic well-being and mitigating age-related cellular deterioration. For example, the International Diabetes Federation, a non-profit organization based in Belgium representing global diabetes associations, projected in February 2025 that the population over 65 years with diabetes would reach 195.2 million (19.6%) by 2030 and 276.2 million by 2045. This forecast underscores a considerable increase in the diabetes burden within aging populations over the next 25 years, carrying substantial public health and economic consequences. Consequently, the growing incidence of age-related and metabolic conditions is stimulating the expansion of the nicotinamide adenine dinucleotide market.

Which Segment Groups Define The Nicotinamide Adenine Dinucleotide Market Landscape?

The nicotinamide adenine dinucleotide market covered in this report is segmented –

1) By Product Type: Oral Nicotinamide Adenine Dinucleotide Supplements, Nicotinamide Adenine Dinucleotide And NADH Direct-Ingredient Capsules, Nicotinamide Adenine Dinucleotide Injection and Infusion Products, Specialized Anti-Aging and Metabolic Formulations, Nicotinamide Adenine Dinucleotide Precursors, Topical and Cosmetic Nicotinamide Adenine Dinucleotide Formulations

2) By Grade: Food Grade, Pharmaceutical Grade, Other Grades

3) By Distribution Channel: Online and E-commerce, Offline Channels

4) By Application: Dietary Supplements and Wellness, Pharmaceuticals and Therapeutics, Cosmetics and Dermatology, Clinical IV Therapy and Regenerative Medicine, Research and Biotechnology

5) By End User: Individual Consumers, Healthcare Providers, Pharmaceutical Companies

Subsegments:

1) By Oral Nicotinamide Adenine Dinucleotide Supplements: Energy Support Tablets, Healthy Aging Capsules, Metabolism Support Powder, Immune Wellness Tablet, Cognitive Support Capsules

2) By Nicotinamide Adenine Dinucleotide And NADH Direct-Ingredient Capsules: Nicotinamide Adenine Dinucleotide Plus Capsules, Nicotinamide Adenine Dinucleotide Reduced Capsules, Cellular Energy Enhancement Capsules, Mitochondrial Support Capsules, High Potency Nicotinamide Adenine Dinucleotide Capsules

3) By Nicotinamide Adenine Dinucleotide Injection and Infusion Products: Intravenous Nicotinamide Adenine Dinucleotide Solutions, Intramuscular Nicotinamide Adenine Dinucleotide Shots, High Concentration Nicotinamide Adenine Dinucleotide Infusions, Detoxification Support Infusions, Regenerative Wellness Infusion Blends

4) By Specialized Anti-Aging and Metabolic Formulations: Cellular Regeneration Formulas, Mitochondrial Activation Formulas, Longevity Support Formulas, Metabolic Enhancement Formulas, Detoxification Support Formulas

5) By Nicotinamide Adenine Dinucleotide Precursors: Nicotinamide Mononucleotide Tablets, Nicotinamide Riboside Capsules, Nicotinamide Tablets, Nicotinamide Adenine Dinucleotide Pathway Support Powders, Healthy Aging Precursor Blends

5) By Topical and Cosmetic Nicotinamide Adenine Dinucleotide Formulations: Anti-Aging Facial Serums, Skin Repair Moisturizers, Brightening Facial Creams, Barrier Strengthening Lotions, Eye Area Rejuvenation Gels

What Trends Are Shaping The Nicotinamide Adenine Dinucleotide Market Structure?

Major companies in the nicotinamide adenine dinucleotide market are prioritizing the development of advanced formulations, such as nicotinamide adenine dinucleotide (NAD+) skincare supplements, to aid in anti-aging and enhance skin health. Nicotinamide adenine dinucleotide (NAD+) skincare supplements are defined as either dietary or topical products engineered to elevate nicotinamide adenine dinucleotide (NAD+) levels within skin cells, thus supporting cellular energy, repair, and anti-aging processes for improved skin health and appearance. For example, in November 2025, ChromaDex Corporation, a US-based NAD+ bioscience company, launched Tru Niagen Beauty, which became the first NAD+ skincare supplement available in the United States. This product contains a precise combination of clinically studied ingredients, including its patented nicotinamide riboside (Niagen). This specific formulation is intended to support cellular energy production, promote skin health, and enhance overall wellness by increasing NAD+ availability, which naturally diminishes with age.

Which Organizations Are Involved In The Nicotinamide Adenine Dinucleotide Market?

Major companies operating in the nicotinamide adenine dinucleotide market are Thermo Fisher Scientific Inc., Life Extension Foundation Buyers Club Inc., Niagen Bioscience Inc., Tokyo Chemical Industry Co. Ltd., Otto Chemie Pvt. Ltd., HiMedia Laboratories Pvt. Ltd., Sichuan Benepure Pharmaceutical, F. Hoffmann-La Roche Ltd, Herbalmax Ltd., Nuray Chemicals Private Limited, Hefei Home Sunshine Pharmaceutical Technology Co. Ltd., Syncozymes Biotechnology Co. Ltd., OYC Americas Inc., Xi’an Yinherb Bio-Tech Co. Ltd., Shenzhen Hygieia Biotechnology Co. Ltd., Zhejiang Dazhan Biotechnology Co. Ltd., Willow Birch Pharma Inc., Hubei AOKS Bio-Tech Co. Ltd., Shanghai Neutan Pharmaceutical Co. Ltd., Evereen (Shanghai) Biotechnology Co. Ltd.

Access The Complete Nicotinamide Adenine Dinucleotide Market Report:

https://www.thebusinessresearchcompany.com/report/nicotinamide-adenine-dinucleotide-market-report

Which Region Is The Primary Market For The Nicotinamide Adenine Dinucleotide Market?

North America was the largest region in the nicotinamide adenine dinucleotide market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nicotinamide adenine dinucleotide market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Nicotinamide Adenine Dinucleotide Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=30680&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the nicotinamide adenine dinucleotide market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Nicotinamide Adenine Dinucleotide Market expected to grow between 2026 and 2030?

The nicotinamide adenine dinucleotide market size has seen substantial growth in recent years. It is anticipated to expand from $5.59 billion in 2025 to $6.48 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 16.1%. The expansion observed in the past can be ascribed to several factors, including the increasing demand for anti-aging supplements, the expanding research into cellular metabolism, a greater awareness of preventive healthcare, the enlargement of nutraceutical distribution channels, and the rising adoption of wellness and biohacking products.

The nicotinamide adenine dinucleotide market is anticipated to show significant expansion in the coming years, with its valuation projected to reach $11.65 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.8%. This expected growth within the forecast period stems from several factors, such as consumers’ increasing expenditure on solutions for longevity and vitality, the rising incorporation of NAD precursors into mainstream dietary supplements, the expanding presence of IV therapy and regenerative clinics, growing pharmaceutical interest in NAD for managing chronic illnesses, and the broader adoption of online personalized supplement programs. Prominent trends for this period include technological improvements in sustained-release and liposomal delivery methods, innovations in multi-ingredient formulations aimed at longevity, the development of NAD-based active ingredients for dermatology and skincare, research and advancements in therapeutic-grade NAD for addressing neurological and metabolic disorders, and progress in biomarker-driven personalized supplementation platforms.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30680&type=smp

Which Drivers Are Influencing Market Acceleration In The Nicotinamide Adenine Dinucleotide Market?

The increasing occurrence of age-related and metabolic disorders is anticipated to fuel the expansion of the nicotinamide adenine dinucleotide market. These health conditions, encompassing diabetes, obesity, cardiovascular diseases, and neurodegenerative disorders, are connected to aging, impaired metabolism, and cellular dysfunction. Their prevalence is on the rise as populations age and unhealthy lifestyle patterns, such as sedentary behavior, excessive calorie intake, and increasing obesity rates, become more widespread. Nicotinamide adenine dinucleotide assists in managing age-related and metabolic disorders by playing a vital role in cellular energy metabolism, mitochondrial function, and DNA repair processes, all of which are crucial for maintaining metabolic health and decelerating age-associated cellular decline. For example, in February 2025, the International Diabetes Federation, a Belgium-based nonprofit organization representing diabetes associations globally, projected that the number of people aged above 65 years with diabetes will reach 195.2 million, constituting 19.6% in 2030, and further rise to 276.2 million in 2045, underscoring a substantial increase in the diabetes burden within aging societies over the next 25 years with significant public health and economic ramifications. Consequently, the rising prevalence of age-related and metabolic disorders is propelling the growth of the nicotinamide adenine dinucleotide market.

What Segments Are Identified Within The Structure Of The Nicotinamide Adenine Dinucleotide Market?

The nicotinamide adenine dinucleotide market covered in this report is segmented –

1) By Product Type: Oral Nicotinamide Adenine Dinucleotide Supplements, Nicotinamide Adenine Dinucleotide And NADH Direct-Ingredient Capsules, Nicotinamide Adenine Dinucleotide Injection and Infusion Products, Specialized Anti-Aging and Metabolic Formulations, Nicotinamide Adenine Dinucleotide Precursors, Topical and Cosmetic Nicotinamide Adenine Dinucleotide Formulations

2) By Grade: Food Grade, Pharmaceutical Grade, Other Grades

3) By Distribution Channel: Online and E-commerce, Offline Channels

4) By Application: Dietary Supplements and Wellness, Pharmaceuticals and Therapeutics, Cosmetics and Dermatology, Clinical IV Therapy and Regenerative Medicine, Research and Biotechnology

5) By End User: Individual Consumers, Healthcare Providers, Pharmaceutical Companies

Subsegments:

1) By Oral Nicotinamide Adenine Dinucleotide Supplements: Energy Support Tablets, Healthy Aging Capsules, Metabolism Support Powder, Immune Wellness Tablet, Cognitive Support Capsules

2) By Nicotinamide Adenine Dinucleotide And NADH Direct-Ingredient Capsules: Nicotinamide Adenine Dinucleotide Plus Capsules, Nicotinamide Adenine Dinucleotide Reduced Capsules, Cellular Energy Enhancement Capsules, Mitochondrial Support Capsules, High Potency Nicotinamide Adenine Dinucleotide Capsules

3) By Nicotinamide Adenine Dinucleotide Injection and Infusion Products: Intravenous Nicotinamide Adenine Dinucleotide Solutions, Intramuscular Nicotinamide Adenine Dinucleotide Shots, High Concentration Nicotinamide Adenine Dinucleotide Infusions, Detoxification Support Infusions, Regenerative Wellness Infusion Blends

4) By Specialized Anti-Aging and Metabolic Formulations: Cellular Regeneration Formulas, Mitochondrial Activation Formulas, Longevity Support Formulas, Metabolic Enhancement Formulas, Detoxification Support Formulas

5) By Nicotinamide Adenine Dinucleotide Precursors: Nicotinamide Mononucleotide Tablets, Nicotinamide Riboside Capsules, Nicotinamide Tablets, Nicotinamide Adenine Dinucleotide Pathway Support Powders, Healthy Aging Precursor Blends

5) By Topical and Cosmetic Nicotinamide Adenine Dinucleotide Formulations: Anti-Aging Facial Serums, Skin Repair Moisturizers, Brightening Facial Creams, Barrier Strengthening Lotions, Eye Area Rejuvenation Gels

What Industry Trends Are Transforming The Nicotinamide Adenine Dinucleotide Market?

Leading companies in the nicotinamide adenine dinucleotide market are prioritizing the development of advanced products, such as nicotinamide adenine dinucleotide (NAD+) skincare supplements, to aid in anti-aging and improve skin health. Nicotinamide adenine dinucleotide (NAD+) skincare supplements are products, either consumed or applied topically, designed to boost nicotinamide adenine dinucleotide (NAD+) levels in skin cells, thereby supporting cellular energy, repair mechanisms, and anti-aging processes to enhance skin health and appearance. For example, in November 2025, ChromaDex Corporation, a US-based NAD+ bioscience company, launched Tru Niagen Beauty, which was the first NAD+ skincare supplement made available in the United States. This product features a precise combination of clinically studied ingredients, including its patented nicotinamide riboside (Niagen). This specific formulation aims to support cellular energy production, skin health, and overall well-being by increasing NAD+ availability, which naturally decreases with age.

Which Major Firms Are Strengthening Their Position In The Nicotinamide Adenine Dinucleotide Market?

Major companies operating in the nicotinamide adenine dinucleotide market are Thermo Fisher Scientific Inc., Life Extension Foundation Buyers Club Inc., Niagen Bioscience Inc., Tokyo Chemical Industry Co. Ltd., Otto Chemie Pvt. Ltd., HiMedia Laboratories Pvt. Ltd., Sichuan Benepure Pharmaceutical, F. Hoffmann-La Roche Ltd, Herbalmax Ltd., Nuray Chemicals Private Limited, Hefei Home Sunshine Pharmaceutical Technology Co. Ltd., Syncozymes Biotechnology Co. Ltd., OYC Americas Inc., Xi’an Yinherb Bio-Tech Co. Ltd., Shenzhen Hygieia Biotechnology Co. Ltd., Zhejiang Dazhan Biotechnology Co. Ltd., Willow Birch Pharma Inc., Hubei AOKS Bio-Tech Co. Ltd., Shanghai Neutan Pharmaceutical Co. Ltd., Evereen (Shanghai) Biotechnology Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/nicotinamide-adenine-dinucleotide-market-report

Which Region Shows The Strongest Potential For Future Expansion In The Nicotinamide Adenine Dinucleotide Market?

North America was the largest region in the nicotinamide adenine dinucleotide market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nicotinamide adenine dinucleotide market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Nicotinamide Adenine Dinucleotide Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30680&type=smp

Browse Through More Reports Similar to the Global Nicotinamide Adenine Dinucleotide Market 2026, By The Business Research Company

Oligonucleotides Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Peptide And Oligonucleotide Cdmo Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-and-oligonucleotide-cdmo-global-market-report

n methyl 2 pyrrolidone nmp market

https://www.thebusinessresearchcompany.com/report/n-methyl-2-pyrrolidone-nmp-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Nicotinamide Adenine Dinucleotide Market During 2026–2030?

The nicotinamide adenine dinucleotide market size has experienced swift expansion recently. This market is projected to expand from $5.59 billion in 2025 to $6.48 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.1%. Historically, this upward trend has been driven by factors such as a surge in the need for anti-aging supplements, advancing research into cellular metabolism, a heightened understanding of preventive healthcare, the broadening of nutraceutical distribution channels, and the increasing uptake of wellness and biohacking items.

The nicotinamide adenine dinucleotide market size is anticipated to expand quickly in the coming years. By 2030, this market is projected to reach $11.65 billion, demonstrating a compound annual growth rate (CAGR) of 15.8%. This projected expansion throughout the forecast period stems from factors such as increasing consumer expenditure on products for longevity and vitality, the rising integration of NAD precursors into common supplements, the growing establishment of IV therapy and regenerative clinics, heightened pharmaceutical interest in NAD for managing chronic diseases, and the wider uptake of online personalized supplement programs. Key developments expected during this timeframe encompass technological progress in sustained-release and liposomal delivery methods, breakthroughs in longevity formulations combining multiple ingredients, the emergence of NAD-based active ingredients for dermatology and skincare, ongoing research and development into therapeutic-grade NAD for addressing neurological and metabolic conditions, and enhancements in personalized supplementation platforms utilizing biomarkers.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30680&type=smp

Which Key Drivers Are Affecting The Nicotinamide Adenine Dinucleotide Market Development?

The nicotinamide adenine dinucleotide market is anticipated to expand due to the increasing occurrence of age-related and metabolic conditions. These conditions encompass health issues such as diabetes, obesity, cardiovascular ailments, and neurodegenerative disorders, all linked to aging, metabolic impairment, and cellular dysfunction. Their rise is fueled by an aging global population and the widespread adoption of unhealthy lifestyles, including sedentary habits, excessive caloric consumption, and growing obesity rates. Nicotinamide adenine dinucleotide plays a crucial role in managing these conditions by supporting cellular energy metabolism, mitochondrial function, and DNA repair, which are vital for maintaining metabolic well-being and mitigating age-related cellular deterioration. For example, in February 2025, the International Diabetes Federation, a Belgium-based non profit organization, forecasted that the number of individuals aged above 65 years with diabetes would reach 195.2 million, representing 19.6%, by 2030, and further increase to 276.2 million by 2045. This indicates a substantial increase in the diabetes burden within aging societies over the next 25 years, carrying significant public health and economic consequences. Consequently, the growing prevalence of age-related and metabolic disorders is a primary factor driving the nicotinamide adenine dinucleotide market’s advancement.

How Is Segmentation Applied In The Nicotinamide Adenine Dinucleotide Market Segment Analysis?

The nicotinamide adenine dinucleotide market covered in this report is segmented –

1) By Product Type: Oral Nicotinamide Adenine Dinucleotide Supplements, Nicotinamide Adenine Dinucleotide And NADH Direct-Ingredient Capsules, Nicotinamide Adenine Dinucleotide Injection and Infusion Products, Specialized Anti-Aging and Metabolic Formulations, Nicotinamide Adenine Dinucleotide Precursors, Topical and Cosmetic Nicotinamide Adenine Dinucleotide Formulations

2) By Grade: Food Grade, Pharmaceutical Grade, Other Grades

3) By Distribution Channel: Online and E-commerce, Offline Channels

4) By Application: Dietary Supplements and Wellness, Pharmaceuticals and Therapeutics, Cosmetics and Dermatology, Clinical IV Therapy and Regenerative Medicine, Research and Biotechnology

5) By End User: Individual Consumers, Healthcare Providers, Pharmaceutical Companies

Subsegments:

1) By Oral Nicotinamide Adenine Dinucleotide Supplements: Energy Support Tablets, Healthy Aging Capsules, Metabolism Support Powder, Immune Wellness Tablet, Cognitive Support Capsules

2) By Nicotinamide Adenine Dinucleotide And NADH Direct-Ingredient Capsules: Nicotinamide Adenine Dinucleotide Plus Capsules, Nicotinamide Adenine Dinucleotide Reduced Capsules, Cellular Energy Enhancement Capsules, Mitochondrial Support Capsules, High Potency Nicotinamide Adenine Dinucleotide Capsules

3) By Nicotinamide Adenine Dinucleotide Injection and Infusion Products: Intravenous Nicotinamide Adenine Dinucleotide Solutions, Intramuscular Nicotinamide Adenine Dinucleotide Shots, High Concentration Nicotinamide Adenine Dinucleotide Infusions, Detoxification Support Infusions, Regenerative Wellness Infusion Blends

4) By Specialized Anti-Aging and Metabolic Formulations: Cellular Regeneration Formulas, Mitochondrial Activation Formulas, Longevity Support Formulas, Metabolic Enhancement Formulas, Detoxification Support Formulas

5) By Nicotinamide Adenine Dinucleotide Precursors: Nicotinamide Mononucleotide Tablets, Nicotinamide Riboside Capsules, Nicotinamide Tablets, Nicotinamide Adenine Dinucleotide Pathway Support Powders, Healthy Aging Precursor Blends

5) By Topical and Cosmetic Nicotinamide Adenine Dinucleotide Formulations: Anti-Aging Facial Serums, Skin Repair Moisturizers, Brightening Facial Creams, Barrier Strengthening Lotions, Eye Area Rejuvenation Gels

What Trends Are Transforming The Nicotinamide Adenine Dinucleotide Market?

Leading companies active in the nicotinamide adenine dinucleotide market are prioritizing the creation of advanced formulations, such as nicotinamide adenine dinucleotide (NAD+) skincare supplements, to aid in anti-aging and enhance skin condition. These nicotinamide adenine dinucleotide (NAD+) skincare supplements encompass either ingestible or topically applied products formulated to elevate nicotinamide adenine dinucleotide (NAD+) concentrations within skin cells, thereby supporting cellular energy, facilitating repair, and fostering anti-aging mechanisms to improve dermal health and appearance. As an illustration, in November 2025, ChromaDex Corporation, a US-based NAD+ bioscience firm, introduced Tru Niagen Beauty, marking it as the initial NAD+ skincare supplement accessible in the United States. This product features a meticulously crafted blend of scientifically validated ingredients, including its patented nicotinamide riboside (Niagen). The design of this formulation aims to bolster cellular energy production, promote skin well-being, and contribute to overall vitality by increasing the availability of NAD+, which typically diminishes with advancing age.

Who Are The Companies Participating In The Nicotinamide Adenine Dinucleotide Market Environment?

Major companies operating in the nicotinamide adenine dinucleotide market are Thermo Fisher Scientific Inc., Life Extension Foundation Buyers Club Inc., Niagen Bioscience Inc., Tokyo Chemical Industry Co. Ltd., Otto Chemie Pvt. Ltd., HiMedia Laboratories Pvt. Ltd., Sichuan Benepure Pharmaceutical, F. Hoffmann-La Roche Ltd, Herbalmax Ltd., Nuray Chemicals Private Limited, Hefei Home Sunshine Pharmaceutical Technology Co. Ltd., Syncozymes Biotechnology Co. Ltd., OYC Americas Inc., Xi’an Yinherb Bio-Tech Co. Ltd., Shenzhen Hygieia Biotechnology Co. Ltd., Zhejiang Dazhan Biotechnology Co. Ltd., Willow Birch Pharma Inc., Hubei AOKS Bio-Tech Co. Ltd., Shanghai Neutan Pharmaceutical Co. Ltd., Evereen (Shanghai) Biotechnology Co. Ltd.

Get The Full Nicotinamide Adenine Dinucleotide Market Report:

https://www.thebusinessresearchcompany.com/report/nicotinamide-adenine-dinucleotide-market-report

Which Region Is The Top Contributor To The Nicotinamide Adenine Dinucleotide Market By Share?

North America was the largest region in the nicotinamide adenine dinucleotide market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nicotinamide adenine dinucleotide market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Nicotinamide Adenine Dinucleotide Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=30680&type=smp

Browse Through More Reports Similar to the Global Nicotinamide Adenine Dinucleotide Market 2026, By The Business Research Company

Oligonucleotides Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Peptide And Oligonucleotide Cdmo Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-and-oligonucleotide-cdmo-global-market-report

n methyl 2 pyrrolidone nmp market

https://www.thebusinessresearchcompany.com/report/n-methyl-2-pyrrolidone-nmp-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Nicotinamide Adenine Dinucleotide Market By The End Of 2030?

The nicotinamide adenine dinucleotide market has shown substantial growth in recent times. It is anticipated to expand from $5.59 billion in 2025 to $6.48 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.1%. This past growth is largely attributable to factors such as the escalating demand for anti-aging supplements, increased research concerning cellular metabolism, a heightened focus on preventive healthcare, the broadening of nutraceutical distribution channels, and the greater adoption of wellness and biohacking products.

The market for nicotinamide adenine dinucleotide is projected to experience substantial expansion in the coming years, anticipated to reach a valuation of $11.65 billion by 2030, demonstrating a robust compound annual growth rate (CAGR) of 15.8%. This projected growth can be attributed to several factors, including heightened consumer expenditure on products promoting longevity and vitality, the increasing integration of NAD precursors into common supplements, the broadening reach of IV therapy and regenerative clinics, a growing focus from the pharmaceutical sector on NAD for managing chronic diseases, and the expanding presence of online personalized supplement programs. Key trends expected during this period involve technological progress in sustained-release and liposomal delivery methods, breakthroughs in multi-ingredient formulations aimed at longevity, the evolution of NAD-based active ingredients for dermatology and skincare, ongoing research and development into therapeutic-grade NAD for neurological and metabolic conditions, and improvements in biomarker-driven personalized supplementation platforms.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30680&type=smp

What Primary Drivers Are Shaping The Development Of The Nicotinamide Adenine Dinucleotide Market?

The growing occurrence of age-related and metabolic conditions is anticipated to drive the expansion of the nicotinamide adenine dinucleotide market in the future. These disorders encompass health issues like diabetes, obesity, cardiovascular ailments, and neurodegenerative conditions, all linked to aging, metabolic impairment, and cellular dysfunction. Their prevalence is increasing due to aging populations and the widespread adoption of unhealthy lifestyles, including sedentary habits, excessive caloric consumption, and escalating obesity rates. Nicotinamide adenine dinucleotide aids in managing these conditions by its vital involvement in cellular energy metabolism, mitochondrial function, and DNA repair, all crucial for upholding metabolic well-being and mitigating age-related cellular deterioration. For example, the International Diabetes Federation, a Belgium-based non-profit organization, forecast in February 2025 that the global population aged over 65 with diabetes will climb to 195.2 million, representing 19.6%, by 2030, and further to 276.2 million by 2045. This underscores a substantial increase in the diabetes burden within aging societies over the next 25 years, carrying significant public health and economic consequences. Consequently, the increasing prevalence of age-related and metabolic disorders is fueling the expansion of the nicotinamide adenine dinucleotide market.

Which Segment Classifications Shape The Nicotinamide Adenine Dinucleotide Market?

The nicotinamide adenine dinucleotide market covered in this report is segmented –

1) By Product Type: Oral Nicotinamide Adenine Dinucleotide Supplements, Nicotinamide Adenine Dinucleotide And NADH Direct-Ingredient Capsules, Nicotinamide Adenine Dinucleotide Injection and Infusion Products, Specialized Anti-Aging and Metabolic Formulations, Nicotinamide Adenine Dinucleotide Precursors, Topical and Cosmetic Nicotinamide Adenine Dinucleotide Formulations

2) By Grade: Food Grade, Pharmaceutical Grade, Other Grades

3) By Distribution Channel: Online and E-commerce, Offline Channels

4) By Application: Dietary Supplements and Wellness, Pharmaceuticals and Therapeutics, Cosmetics and Dermatology, Clinical IV Therapy and Regenerative Medicine, Research and Biotechnology

5) By End User: Individual Consumers, Healthcare Providers, Pharmaceutical Companies

Subsegments:

1) By Oral Nicotinamide Adenine Dinucleotide Supplements: Energy Support Tablets, Healthy Aging Capsules, Metabolism Support Powder, Immune Wellness Tablet, Cognitive Support Capsules

2) By Nicotinamide Adenine Dinucleotide And NADH Direct-Ingredient Capsules: Nicotinamide Adenine Dinucleotide Plus Capsules, Nicotinamide Adenine Dinucleotide Reduced Capsules, Cellular Energy Enhancement Capsules, Mitochondrial Support Capsules, High Potency Nicotinamide Adenine Dinucleotide Capsules

3) By Nicotinamide Adenine Dinucleotide Injection and Infusion Products: Intravenous Nicotinamide Adenine Dinucleotide Solutions, Intramuscular Nicotinamide Adenine Dinucleotide Shots, High Concentration Nicotinamide Adenine Dinucleotide Infusions, Detoxification Support Infusions, Regenerative Wellness Infusion Blends

4) By Specialized Anti-Aging and Metabolic Formulations: Cellular Regeneration Formulas, Mitochondrial Activation Formulas, Longevity Support Formulas, Metabolic Enhancement Formulas, Detoxification Support Formulas

5) By Nicotinamide Adenine Dinucleotide Precursors: Nicotinamide Mononucleotide Tablets, Nicotinamide Riboside Capsules, Nicotinamide Tablets, Nicotinamide Adenine Dinucleotide Pathway Support Powders, Healthy Aging Precursor Blends

5) By Topical and Cosmetic Nicotinamide Adenine Dinucleotide Formulations: Anti-Aging Facial Serums, Skin Repair Moisturizers, Brightening Facial Creams, Barrier Strengthening Lotions, Eye Area Rejuvenation Gels

How Are Trends Impacting The Nicotinamide Adenine Dinucleotide Market?

Leading companies within the nicotinamide adenine dinucleotide market are concentrating on developing advanced formulations, such as nicotinamide adenine dinucleotide (NAD+) skincare supplements, to aid in anti-aging and enhance skin health. Nicotinamide adenine dinucleotide (NAD+) skincare supplements are defined as dietary or topical products engineered to elevate nicotinamide adenine dinucleotide (NAD+) levels in skin cells, thereby supporting cellular energy, repair, and anti-aging processes to improve skin health and appearance. For example, in November 2025, ChromaDex Corporation, a US-based NAD+ bioscience company, unveiled Tru Niagen Beauty, the first NAD+ skincare supplement made available in the United States, incorporating a precise combination of clinically investigated ingredients, including its patented nicotinamide riboside (Niagen). This specific formulation is crafted to bolster cellular energy production, skin vitality, and overall wellness by boosting NAD+ availability, which naturally diminishes with advancing age.

Who Are The Top Market Participants Influencing The Nicotinamide Adenine Dinucleotide Market?

Major companies operating in the nicotinamide adenine dinucleotide market are Thermo Fisher Scientific Inc., Life Extension Foundation Buyers Club Inc., Niagen Bioscience Inc., Tokyo Chemical Industry Co. Ltd., Otto Chemie Pvt. Ltd., HiMedia Laboratories Pvt. Ltd., Sichuan Benepure Pharmaceutical, F. Hoffmann-La Roche Ltd, Herbalmax Ltd., Nuray Chemicals Private Limited, Hefei Home Sunshine Pharmaceutical Technology Co. Ltd., Syncozymes Biotechnology Co. Ltd., OYC Americas Inc., Xi’an Yinherb Bio-Tech Co. Ltd., Shenzhen Hygieia Biotechnology Co. Ltd., Zhejiang Dazhan Biotechnology Co. Ltd., Willow Birch Pharma Inc., Hubei AOKS Bio-Tech Co. Ltd., Shanghai Neutan Pharmaceutical Co. Ltd., Evereen (Shanghai) Biotechnology Co. Ltd.

Read the full nicotinamide adenine dinucleotide market report here:

https://www.thebusinessresearchcompany.com/report/nicotinamide-adenine-dinucleotide-market-report

Which Region Is Anticipated To See The Fastest Growth In The Nicotinamide Adenine Dinucleotide Market?

North America was the largest region in the nicotinamide adenine dinucleotide market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nicotinamide adenine dinucleotide market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Nicotinamide Adenine Dinucleotide Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30680&type=smp

Browse Through More Reports Similar to the Global Nicotinamide Adenine Dinucleotide Market 2026, By The Business Research Company

Oligonucleotides Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Peptide And Oligonucleotide Cdmo Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-and-oligonucleotide-cdmo-global-market-report

n methyl 2 pyrrolidone nmp market

https://www.thebusinessresearchcompany.com/report/n-methyl-2-pyrrolidone-nmp-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model